The store will not work correctly when cookies are disabled.
N-(3-Ethylphenyl)-8-hydroxy-2-imino-2H-chromene-3-carboxamide
ID: ALA4646593
Chembl Id: CHEMBL4646593
PubChem CID: 150819982
Max Phase: Preclinical
Molecular Formula: C18H16N2O3
Molecular Weight: 308.34
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CCc1cccc(NC(=O)c2cc3cccc(O)c3oc2=N)c1
Standard InChI: InChI=1S/C18H16N2O3/c1-2-11-5-3-7-13(9-11)20-18(22)14-10-12-6-4-8-15(21)16(12)23-17(14)19/h3-10,19,21H,2H2,1H3,(H,20,22)
Standard InChI Key: KJSIIAIZHJYKDK-UHFFFAOYSA-N
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 308.34 | Molecular Weight (Monoisotopic): 308.1161 | AlogP: 3.43 | #Rotatable Bonds: 3 |
Polar Surface Area: 86.32 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.24 | CX Basic pKa: 4.56 | CX LogP: 4.12 | CX LogD: 4.12 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.69 | Np Likeness Score: -0.75 |
References
1. Endo S, Oguri H, Segawa J, Kawai M, Hu D, Xia S, Okada T, Irie K, Fujii S, Gouda H, Iguchi K, Matsukawa T, Fujimoto N, Nakayama T, Toyooka N, Matsunaga T, Ikari A.. (2020) Development of Novel AKR1C3 Inhibitors as New Potential Treatment for Castration-Resistant Prostate Cancer., 63 (18): [PMID:32847363] [10.1021/acs.jmedchem.0c00939] |